Project description
A B2B online platform for remote dosimetry
Radiotherapy is one of the principal cancer treatments, and its application is growing across the world. Designing a radiotherapy treatment plan requires skilled staff to maximise effectiveness and minimise the impact on surrounding tissue and organs. The task is increasingly complex, as hospitals deploy the latest treatment techniques. To facilitate this, the EU-funded Mercurius Connect project has developed a platform where radiotherapy centres can find specialised dosimetrists to perform clinical dosimetries on demand. The platform offers high-quality service and will have a greater impact in low-and-middle-income countries that have a lack of access to trained qualified staff.
Objective
Cancer is one of the most deadly diseases on the planet and radiotherapy (RT), a pillar treatment in the fight against it.
Imagine that patients from all over the world could have access to the most specialized RT professionals and that waiting times for treatment could be diminished. This is what we are proposing with Mercurius Connect platform, a Gig economy marketplace where RT Centres can find highly specialised dosimetrists, from all over the world, to perform clinical dosimetries on demand.
The creation of a clinical dosimetry, a treatment plan, that determines a set of radiation fields, which will deliver the prescribed radiation dose to a delimited tumour volume, while minimizing the impact on surrounding tissue/organs, is one of the most complex and time-consuming tasks in RT.
Mercurius Connect provides to RT Centres the possibility to get a high-quality service, while diminishing inefficiencies related with over or underestimation of the number of required professionals. On the other hand, the solution offers to RT Centres in low-and-middle-income countries, access to highly specialised radiotherapy professionals, where the lack of these resources is a huge challenge.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
1250 050 LISBOA
Portugal
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.